Androgen News and Research

RSS

UTHSC's drug candidate for advanced prostate cancer goes to first clinical trial

A drug candidate developed by researchers at the University of Tennessee Health Science Center for advanced metastatic castration-resistant prostate cancer is now in its first clinical trial.

6 Nov 2023

Docetaxel improves survival in men with high-grade prostate cancer and low PSA

Men with high-grade prostate cancer and low prostate-specific antigen (PSA) levels have a poor prognosis.

1 Nov 2023

Ketogenic diet boosts IVF success for women with PCOS, study reveals

A recent study in the journal "Nutrients" investigated the effects of dietary interventions, including the Mediterranean diet (MD) and a very low-calorie ketogenic diet (VLCKD), on overweight or obese women with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilization (IVF).

24 Oct 2023

Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Researchers discuss the results of a randomized controlled trial to explore the impact of diet on breast cancer recurrence.

20 Oct 2023

Scientists identify two promising new treatment options for men with recurrent prostate cancer

Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer-; both of which helped patients live longer without their disease progressing than the current standard treatment.

18 Oct 2023

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer.

11 Oct 2023

Altering certain molecular interactions could yield new strategies for treating prostate cancer

Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered that altering certain molecular interactions could yield new strategies for treating prostate cancer and related diseases.

6 Oct 2023

Can human chorionic gonadotropin supplements enhance penile growth?

Whether human chorionic gonadotropin could expedite tunica albuginea restructuring to aid penile development.

4 Oct 2023

New drugs have increased survival rates for men with metastatic prostate cancer

Survival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of 'dual treatment' since 2016.

3 Oct 2023

Key player in ovarian cancer may have implications for PCOS

Researchers explore the involvement and altered expression of BBOX1-AS1 and microRNA-19b in polycystic ovary syndrome.

26 Sep 2023

Rare genetic variants involved in male-pattern hair loss identified

A receding hairline, a total loss of hair from the crown, and ultimately, the classical horseshoe-shaped pattern of baldness: Previous research into male pattern hair loss, also termed androgenetic alopecia, has implicated multiple common genetic variants.

22 Sep 2023

New treatment approach effectively treats the most aggressive forms of prostate cancer

Researchers at the University of Chicago Medicine Comprehensive Cancer Center established "proof-of-concept" for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.

19 Sep 2023

Mesenchymal stem cell-derived extracellular vesicles show promise in PCOS treatment

Polycystic ovary syndrome (PCOS) is a pervasive endocrine disorder that affects millions of women globally, impacting their hormonal balance, fertility and overall well-being.

12 Sep 2023

Ketogenic diet shows promise in addressing hormonal imbalance associated with PCOS

Researchers performed a meta-analysis on the impact of ketogenic diets on polycystic ovary syndrome (PCOS).

8 Sep 2023

NSAID use linked to higher risk of blood clots in women of reproductive age, association stronger in women on high-risk hormonal contraception

A new paper published in The BMJ explores the effect of these drugs used concomitantly on the risk of venous thromboembolism (VTE).

8 Sep 2023

Is a very low-calorie diet the answer to Polycystic Ovary Syndrome (PCOS)?

The effects of a very low-calorie diet to a moderate energy deficit diet in obese women with PCOS.

8 Sep 2023

Keto diet may lower testosterone levels in women with PCOS

The ketogenic (keto) diet may lower testosterone levels in women with polycystic ovary syndrome (PCOS), according to a new paper published in the Journal of the Endocrine Society.

8 Sep 2023

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with 177Lu-PSMA radionuclide therapy.

5 Sep 2023

Sex hormones drive differences in male and female mouse kidneys

Female kidneys are known to be more resilient to disease and injury, but males need not despair. A new USC Stem Cell-led study published in Developmental Cell describes not only how sex hormones drive differences in male and female mouse kidneys, but also how lowering testosterone can "feminize" this organ and improve its resilience.

5 Sep 2023

The efficacy and safety of anti-androgens in the management of hormonal and clinical features of PCOS

The safety and efficacy of anti-androgens in managing polycystic ovary syndrome (PCOS).

1 Sep 2023

Androgen News and Research

UTHSC's drug candidate for advanced prostate cancer goes to first clinical trial

Docetaxel improves survival in men with high-grade prostate cancer and low PSA

Ketogenic diet boosts IVF success for women with PCOS, study reveals

Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Scientists identify two promising new treatment options for men with recurrent prostate cancer

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

Altering certain molecular interactions could yield new strategies for treating prostate cancer

Can human chorionic gonadotropin supplements enhance penile growth?

New drugs have increased survival rates for men with metastatic prostate cancer

Key player in ovarian cancer may have implications for PCOS

Rare genetic variants involved in male-pattern hair loss identified

New treatment approach effectively treats the most aggressive forms of prostate cancer

Mesenchymal stem cell-derived extracellular vesicles show promise in PCOS treatment

Ketogenic diet shows promise in addressing hormonal imbalance associated with PCOS

NSAID use linked to higher risk of blood clots in women of reproductive age, association stronger in women on high-risk hormonal contraception

Is a very low-calorie diet the answer to Polycystic Ovary Syndrome (PCOS)?

Keto diet may lower testosterone levels in women with PCOS

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

Sex hormones drive differences in male and female mouse kidneys

The efficacy and safety of anti-androgens in the management of hormonal and clinical features of PCOS

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Latest News